Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration is a research paper published in Journal of Controlled Release (2020). On theSindex it has a DataRank of 0. It has been cited 120 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Science Foundation
Grant: CBET-1554623
Melanoma Research Alliance
Grant: 503565
Congressionally Directed Medical Research Programs
Grant: BC170037
National Institutes of Health
Grant: 5P30 CA684850-19
National Institutes of Health
Grant: R01 CA245134
Vanderbilt-Ingram Cancer Center
Grant: P30 CA68485
Susan G. Komen
Grant: CCR19609205
American Association for Cancer Research
Grant: SU2C-AACR-IRG 20-17
NCI NIH HHS
Grant: P30 CA068485
NCI NIH HHS
Grant: P50 CA098131
NIDDK NIH HHS
Grant: P30 DK058404
National Institutes of Health
Grant: 5R01CA245134-05
Expanding the Therapeutic Window of Nanoparticle STING Agonists for Cancer Immunotherapy
National Science Foundation
Grant: 1554623
CAREER: Engineering Polymeric Nanomaterials for Programming Innate Immunity
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 3P30CA068485-23S2
Cancer Center Support Grant
National Cancer Institute
Vanderbilt Institute of Nanoscale Science and Engineering, Vanderbilt University
Canadian Institutes of Health Research
Entertainment Industry Foundation
FWCI
4.08
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals